Furthermore, Zhao et al. demonstrated that blockage of this pathway enhanced anti-melanoma immunity and increased the activity of anti-PD-1 immunotherapy in a transgenic mouse melanoma model [118]. This evidence concerns the gene PDCD1 and melanoma.